We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$576B
AUM Growth
+$48.6B
Cap. Flow
-$29.1B
Cap. Flow %
-5.06%
Top 10 Hldgs %
27.06%
Holding
15,819
New
1,459
Increased
5,619
Reduced
5,141
Closed
3,524

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$820M
2
MSFT icon
Microsoft
MSFT
+$811M
3
MCD icon
McDonald's
MCD
+$804M
4
KO icon
Coca-Cola
KO
+$655M
5
AMZN icon
Amazon
AMZN
+$646M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.64B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.1B
3
MSTR icon
Strategy Inc
MSTR
+$564M
4
KR icon
Kroger
KR
+$558M
5
DHR icon
Danaher
DHR
+$494M

Sector Composition

Rank Sector Weight
1 Technology 3.33%
2 Healthcare 3.23%
3 Consumer Discretionary 2.55%
4 Financials 2.55%
5 Industrials 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEX icon
10476
CALL
Kirby Corp
KEX
$7.32B
$215K ﹤0.01%
1,900
-26,500
-93% -$2.78M
DNLI icon
10477
PUT
Denali Therapeutics
DNLI
$3.9B
$215K ﹤0.01%
15,400
+7,500
+95% +$106K
HRMY icon
10478
PUT
Harmony Biosciences
HRMY
$2.22B
$215K ﹤0.01%
6,800
-4,000
-37% -$129K
BV icon
10479
PUT
BrightView Holdings
BV
$1.09B
$215K ﹤0.01%
12,900
+600
+5% +$8.97K
IDU icon
10480
iShares US Utilities ETF
IDU
$1.38B
$215K ﹤0.01%
2,052
SMLL
10481
Harbor Active Small Cap ETF
SMLL
$14.5M
$215K ﹤0.01%
10,078
-8,004
-44% -$163K
LQAI icon
10482
LG QRAFT AI-Powered US Large Cap Core ETF
LQAI
$2.35M
$214K ﹤0.01%
+6,078
New +$199K
GEF icon
10483
PUT
Greif
GEF
$4.97B
$214K ﹤0.01%
3,300
-600
-15% -$34.1K
TPVG icon
10484
TriplePoint Venture Growth BDC
TPVG
$221M
$214K ﹤0.01%
30,558
-103,514
-77% -$678K
IVRA
10485
DELISTED
Invesco Real Assets ESG ETF
IVRA
$214K ﹤0.01%
13,147
-48,271
-79% -$768K
HELP
10486
PUT
Cybin Inc
HELP
$743M
$214K ﹤0.01%
25,500
+18,000
+240% +$131K
WVE icon
10487
PUT
Wave Life Sciences
WVE
$1.07B
$214K ﹤0.01%
32,900
-29,800
-48% -$197K
VOE icon
10488
PUT
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
$214K ﹤0.01%
1,300
OBDC icon
10489
CALL
Blue Owl Capital
OBDC
$5.78B
$214K ﹤0.01%
14,900
+6,900
+86% +$98K
PLDR
10490
DELISTED
Putnam Sustainable Leaders ETF
PLDR
$214K ﹤0.01%
6,326
-10,433
-62% -$326K
LCTX icon
10491
CALL
Lineage Cell Therapeutics
LCTX
$271M
$214K ﹤0.01%
235,400
+227,400
+2,843% +$135K
RGNX icon
10492
PUT
Regenxbio
RGNX
$711M
$213K ﹤0.01%
26,000
-8,300
-24% -$69.5K
NBET
10493
Neuberger Energy Transition & Infrastructure ETF
NBET
$48.9M
$213K ﹤0.01%
+6,499
New +$206K
GSAT icon
10494
Globalstar
GSAT
$10.7B
$213K ﹤0.01%
9,061
-18,114
-67% -$365K
TLH icon
10495
PUT
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
$213K ﹤0.01%
2,100
-10,700
-84% -$1.07M
LNSR icon
10496
CALL
LENSAR
LNSR
$101M
$213K ﹤0.01%
16,200
-14,400
-47% -$194K
FDVV icon
10497
PUT
Fidelity High Dividend ETF
FDVV
$10.5B
$213K ﹤0.01%
4,100
+2,400
+141% +$118K
VG
10498
Venture Global Inc
VG
$35B
$213K ﹤0.01%
13,688
-3,600,667
-100% -$41.6M
HLNE icon
10499
PUT
Hamilton Lane
HLNE
$5.74B
$213K ﹤0.01%
1,500
+100
+7% +$15.1K
LXRX icon
10500
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$213K ﹤0.01%
225,300
+87,600
+64% +$56.8K

Similar funds

Ken Griffin's Q2 2025 Portfolio in Review

As of Q2 2025, Ken Griffin held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in Walmart Inc worth $401M.

  • Ken Griffin's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
  • Ken Griffin added most to NVIDIA in Q2 2025, an estimated $820M increase.
  • Ken Griffin's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
  • Ken Griffin fully exited Kroger in Q2 2025, selling an estimated $558M.
  • Ken Griffin's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
  • Ken Griffin opened 1,459 new positions and closed 3,524 in Q2 2025.
  • Ken Griffin's portfolio value rose 9.2% quarter-over-quarter to $576B.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.